Dr. Eyal Kalo, R&D Director of Innocan Pharma, added "LPT-CBD demonstrates sustained pharmacokinetics and has shown efficacy in multiple animal models of chronic pain. We are extremely proud of this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback